David Scott Moore
Director at Corvus Pharmaceuticals, Inc. (CRVS)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+10.2%
vs. S&P 500+9.1%
Beat the market100%
Paper profit on buys−$22K
Total bought / sold$250K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 15SEC | CRVSCorvus Pharmaceuticals, Inc. | Buy | 21,700new position | $11.53 | $250K | -8.8% |
- Buy
Director David Scott Moore bought $250K of CRVS at $11.53 — first open-market purchase in our records; opens a new position.